{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:14:29Z","timestamp":1773051269829,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.ahj.2005.06.032","type":"journal-article","created":{"date-parts":[[2005,11,11]],"date-time":"2005-11-11T07:14:42Z","timestamp":1131693282000},"page":"1064.e7-1064.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Effect of C-reactive protein reduction on paroxysmal atrial fibrillation"],"prefix":"10.1016","volume":"150","author":[{"given":"John","family":"Dernellis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Panaretou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.06.032_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2143\/AC.56.6.2005701","article-title":"C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation","volume":"56","author":"Dernellis","year":"2001","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.ahj.2005.06.032_bib2","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.06.032_bib3","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.amjcard.2003.08.023","article-title":"Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion","volume":"92","author":"Siu","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.06.032_bib4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ehj.2004.04.025","article-title":"Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation","volume":"25","author":"Dernellis","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.06.032_bib5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.amjcard.2003.08.040","article-title":"Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease","volume":"92","author":"Young-Xu","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.06.032_bib6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ehj.2004.04.035","article-title":"New hope for the prevention of recurrent atrial fibrillation","volume":"25","author":"Abdelhadi","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.06.032_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1253\/circj.67.133","article-title":"Monitoring the progression of the atrial electrical remodeling in patients with paroxysmal atrial fibrillation","volume":"67","author":"Niwano","year":"2003","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2005.06.032_bib8","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1161\/01.CIR.96.10.3542","article-title":"Activation of the complement system during and after cardiopulmonary bypass surgery. Post-surgery activation involves C-reactive protein and is associated with postoperative arrhythmia","volume":"96","author":"Bruins","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.06.032_bib9","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.4049\/jimmunol.112.6.2135","article-title":"Interaction of C-reactive protein complexes with the complement system","volume":"6","author":"Kaplan","year":"1974","journal-title":"J Immunol"},{"key":"10.1016\/j.ahj.2005.06.032_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/281155a0","article-title":"Interaction of C-reactive protein with artificial phosphatidylcholine bilayers","volume":"281","author":"Volanakis","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2005.06.032_bib11","first-page":"H410","article-title":"Influence of long chain acylcarnitines on the voltage-dependent calcium current in adult ventricular myocytes","volume":"263","author":"Wu","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ahj.2005.06.032_bib12","first-page":"145","article-title":"Standardisierung der Bestimmung von 14 Proteinen in Human-Serum auf der Basis des neuen IFCC\/BCR\/CAP Internationalen Referenzmaterials CRM 470","volume":"20","author":"Baudner","year":"1996","journal-title":"J Lab Med"},{"key":"10.1016\/j.ahj.2005.06.032_bib13","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1540-8159.1995.tb06972.x","article-title":"Identification of atrial fibrillation episodes in ambulatory electrocardiographic recordings: validation of a method for obtaining labelled RR interval files","volume":"18","author":"Murgatroyd","year":"1995","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ahj.2005.06.032_bib14","series-title":"Atrial fibrillation","first-page":"134","article-title":"Atrial fibrillation: course and prognosis: a follow-up study of 1212 cases","author":"Godtfredsen","year":"1982"},{"key":"10.1016\/j.ahj.2005.06.032_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1536\/ihj.22.143","article-title":"Clinical features of paroxysmal atrial fibrillation: an observation of 94 patients","volume":"22","author":"Takahashi","year":"1981","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.ahj.2005.06.032_bib16","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","volume":"104","author":"Fuster","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.06.032_bib17","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/01.STR.0000131269.69502.d9","article-title":"Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack","volume":"35","author":"Jabaudon","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2005.06.032_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.89.1.224","article-title":"Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia","volume":"89","author":"Page","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.06.032_bib19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1540-8159.1999.tb00574.x","article-title":"Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke","volume":"22","author":"Schuchert","year":"1999","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ahj.2005.06.032_bib20","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/01.CIR.0000118472.77237.FA","article-title":"Analysis of cause-specific mortality in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study","volume":"109","author":"Steinberg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.06.032_bib21","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.06.032_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0167-5273(96)02631-9","article-title":"The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone","volume":"54","author":"Wolk","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2005.06.032_bib23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin and risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.06.032_bib24","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.06.032_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.06.032_bib26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.amjcard.2004.07.108","article-title":"Frequency of elevation of C-reactive protein in atrial fibrillation","volume":"94","author":"Anderson","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.06.032_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cardiores.2004.01.018","article-title":"The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model","volume":"62","author":"Kumagai","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2005.06.032_bib28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin and risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.06.032_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cardiores.2003.08.014","article-title":"Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways","volume":"60","author":"Cardin","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2005.06.032_bib30","first-page":"31","article-title":"Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling","volume":"20","author":"Healey","year":"2005","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ahj.2005.06.032_bib31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2004.09.033","article-title":"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)","volume":"149","author":"Maggioni","year":"2005","journal-title":"Am Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305006472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305006472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:17:38Z","timestamp":1757567858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870305006472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0002870305006472"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.06.032","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of C-reactive protein reduction on paroxysmal atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}